Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
BioMedicine (Taiwan) is Scopus-indexed (Q1, CiteScore 4.2), WoS ESCI, DOAJ. Published by China Medical University.
Checked against the index lists dated .
ISSN 2211-8020Verify ISSN ↗2211-8039Verify ISSN ↗
Publisher: China Medical University
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Medicine (all) | 127 / 669 | 81st | Q1 |
| Biochemistry, Genetics and Molecular Biology (all) | 93 / 223 | 58th | Q2 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2011–present, best quartile Q1, CiteScore 4.2.
BioMedicine (Taiwan) is Q1 in Medicine (all) (rank 127 of 669) and Q2 in Biochemistry, Genetics and Molecular Biology (all) (rank 93 of 223), by CiteScore 2025.
BioMedicine (Taiwan) is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 4.2, which places it in quartile Q1 at the 81st percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.585, quartile Q2, with an H-index of 38.
BioMedicine (Taiwan) is published by China Medical University. Its print ISSN is 2211-8020 and its online ISSN is 2211-8039.
Yes — indexed in the Emerging Sources Citation Index.
Yes — it is an open-access journal, listed in DOAJ.
BioMedicine (Taiwan) has an h-index of 44 and a 2-year mean of 1.02 citations per paper (OpenAlex). Its Scopus CiteScore is 4.2, quartile Q1. On 2-year citations it ranks #256 of 646 Scopus journals in Medicine (all).
BioMedicine (Taiwan) published 27 papers in 2025; its busiest recent year was 2024 with 185. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 59 research articles (2024–2026), authors are most often from Taiwan (54%), Indonesia (7.6%) and India (6.8%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.